Relation of N-Terminal Pro-B-Type Natriuretic Peptide to Symptoms, Severity, and Left Ventricular Remodeling in Patients With Organic Mitral Regurgitation

American Journal of Cardiology

Volumn 104, Issue 4, 2009, Pages 559-564

  Potocki, Mihael ^a,d   Mair, Johannes ^b   Weber, Michael ^c   Hamm, Christian ^a   Burkard, Thilo ^a   Hiemetzberger, Renate ^b   Peters, Klaus ^d   Jander, Nikolaus ^d   Cron, Thomas A ^e   Hess, Niklaus ^e   Hoffmann, Andreas ^e   Gekeler, Helmut ^f   Gohlke Bärwolf, Christa ^d   Buser, Peter ^a   Mueller, Christian ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c KERCKHOFF HEART CENTER   (Germany)

^d UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

^e Loerrach ^*

^f Loerrach   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CREATININE;

ADULT; AGE; AGED; ARTICLE; CREATININE BLOOD LEVEL; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; FUNCTIONAL ASSESSMENT; GENDER; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE REMODELING; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; PREDICTION; PRIORITY JOURNAL; SYMPTOM; SYSTOLE;

AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; VENTRICULAR REMODELING;

EID: 67949121603     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.04.023     Document Type: Article

References (30)

1. Bonow R.O., Carabello B.A., Kanu C., de Leon Jr. A.C., Faxon D.P., Freed M.D., Gaasch W.H., Lytle B.W., Nishimura R.A., O'Gara P.T., O'Rourke R.A., Otto C.M., Shah P.M., Shanewise J.S., Smith Jr. S.C., Jacobs A.K., Adams C.D., Anderson J.L., Antman E.M., Faxon D.P., Fuster V., Halperin J.L., Hiratzka L.F., Hunt S.A., Lytle B.W., Nishimura R., Page R.L., and Riegel B. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 114 (2006) e84-e231
2. Enriquez-Sarano M., Tajik A.J., Schaff H.V., Orszulak T.A., Bailey K.R., and Frye R.L. Echocardiographic prediction of survival after surgical correction of organic mitral regurgitation. Circulation 90 (1994) 830-837
3. Kang D.H., Kim J.H., Rim J.H., Kim M.J., Yun S.C., Song J.M., Song H., Choi K.J., Song J.K., and Lee J.W. Comparison of early surgery versus conventional treatment in asymptomatic severe mitral regurgitation. Circulation 119 (2009) 797-804
4. Tribouilloy C.M., Enriquez-Sarano M., Schaff H.V., Orszulak T.A., Bailey K.R., Tajik A.J., and Frye R.L. Impact of preoperative symptoms on survival after surgical correction of organic mitral regurgitation: rationale for optimizing surgical indications. Circulation 99 (1999) 400-405
5. Ross Jr. J. The timing of surgery for severe mitral regurgitation. N Engl J Med 335 (1996) 1456-1458
6. Mueller C., Breidthardt T., Laule-Kilian K., Christ M., and Perruchoud A.P. The integration of BNP and NT-proBNP into clinical medicine. Swiss Med Wkly 137 (2007) 4-12
7. McCullough P.A., Nowak R.M., McCord J., Hollander J.E., Herrmann H.C., Steg P.G., Duc P., Westheim A., Omland T., Knudsen C.W., Storrow A.B., Abraham W.T., Lamba S., Wu A.H., Perez A., Clopton P., Krishnaswamy P., Kazanegra R., and Maisel A.S. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation 106 (2002) 416-422
8. Mueller C., Scholer A., Laule-Kilian K., Martina B., Schindler C., Buser P., Pfisterer M., and Perruchoud A.P. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 350 (2004) 647-654
9. Gerber I.L., Stewart R.A., Legget M.E., West T.M., French R.L., Sutton T.M., Yandle T.G., French J.K., Richards A.M., and White H.D. Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis. Circulation 107 (2003) 1884-1890
10. Brookes C.I., Kemp M.W., Hooper J., Oldershaw P.J., and Moat N.E. Plasma brain natriuretic peptide concentrations in patients with chronic mitral regurgitation. J Heart Valve Dis 6 (1997) 608-612
11. Sutton T.M., Stewart R.A., Gerber I.L., West T.M., Richards A.M., Yandle T.G., and Kerr A.J. Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation. J Am Coll Cardiol 41 (2003) 2280-2287
12. Lang R.M., Bierig M., Devereux R.B., Flachskampf F.A., Foster E., Pellikka P.A., Picard M.H., Roman M.J., Seward J., Shanewise J.S., Solomon S.D., Spencer K.T., Sutton M.S., and Stewart W.J. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18 (2005) 1440-1463
13. Hall S.A., Brickner M.E., Willett D.L., Irani W.N., Afridi I., and Grayburn P.A. Assessment of mitral regurgitation severity by Doppler color flow mapping of the vena contracta. Circulation 95 (1997) 636-642
14. Thomas L., Foster E., Hoffman J.I., and Schiller N.B. The Mitral Regurgitation Index: an echocardiographic guide to severity. J Am Coll Cardiol 33 (1999) 2016-2022
15. Enriquez-Sarano M., Miller Jr. F.A., Hayes S.N., Bailey K.R., Tajik A.J., and Seward J.B. Effective mitral regurgitant orifice area: clinical use and pitfalls of the proximal isovelocity surface area method. J Am Coll Cardiol 25 (1995) 703-709
16. Quinones M.A., Otto C.M., Stoddard M., Waggoner A., and Zoghbi W.A. Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 15 (2002) 167-184
17. Collinson P.O., Barnes S.C., Gaze D.C., Galasko G., Lahiri A., and Senior R. Analytical performance of the N terminal pro B type natriuretic peptide (NT-proBNP) assay on the Elecsys 1010 and 2010 analysers. Eur J Heart Fail 6 (2004) 365-368
18. Hanley J.A., and McNeil B.J. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148 (1983) 839-843
19. Enriquez-Sarano M., Avierinos J.F., Messika-Zeitoun D., Detaint D., Capps M., Nkomo V., Scott C., Schaff H.V., and Tajik A.J. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med 352 (2005) 875-883
20. Ling L.H., Enriquez-Sarano M., Seward J.B., Tajik A.J., Schaff H.V., Bailey K.R., and Frye R.L. Clinical outcome of mitral regurgitation due to flail leaflet. N Engl J Med 335 (1996) 1417-1423
21. Borow K.M., Green L.H., Mann T., Sloss L.J., Braunwald E., Collins J.J., Cohn L., and Grossman W. End-systolic volume as a predictor of postoperative left ventricular performance in volume overload from valvular regurgitation. Am J Med 68 (1980) 655-663
22. Wisenbaugh T., Skudicky D., and Sareli P. Prediction of outcome after valve replacement for rheumatic mitral regurgitation in the era of chordal preservation. Circulation 89 (1994) 191-197
23. Zile M.R., Gaasch W.H., Carroll J.D., and Levine H.J. Chronic mitral regurgitation: predictive value of preoperative echocardiographic indexes of left ventricular function and wall stress. J Am Coll Cardiol 3 (1984) 235-242
24. Flemming M.A., Oral H., Rothman E.D., Briesmiester K., Petrusha J.A., and Starling M.R. Echocardiographic markers for mitral valve surgery to preserve left ventricular performance in mitral regurgitation. Am Heart J 140 (2000) 476-482
25. Detaint D., Messika-Zeitoun D., Avierinos J.F., Scott C., Chen H., Burnett Jr. J.C., and Enriquez-Sarano M. B-type natriuretic peptide in organic mitral regurgitation: determinants and impact on outcome. Circulation 111 (2005) 2391-2397
26. Watanabe M., Murakami M., Furukawa H., and Nakahara H. Is measurement of plasma brain natriuretic peptide levels a useful test to detect for surgical timing of valve disease?. Int J Cardiol 96 (2004) 21-24
27. McDonagh T.A., Morrison C.E., Lawrence A., Ford I., Tunstall-Pedoe H., McMurray J.J., and Dargie H.J. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet 350 (1997) 829-833
28. Redfield M.M., Jacobsen S.J., Burnett Jr. J.C., Mahoney D.W., Bailey K.R., and Rodeheffer R.J. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 289 (2003) 194-202
29. Detaint D., Messika-Zeitoun D., Chen H.H., Rossi A., Avierinos J.F., Scott C., Burnett Jr. J.C., and Enriquez-Sarano M. Association of B-type natriuretic peptide activation to left ventricular end-systolic remodeling in organic and functional mitral regurgitation. Am J Cardiol 97 (2006) 1029-1034
30. Thomas N., Unsworth B., Ferenczi E.A., Davies J.E., Mayet J., and Francis D.P. Intraobserver variability in grading severity of repeated identical cases of mitral regurgitation. Am Heart J 156 (2008) 1089-1094